About
Name | Glen Baker |
University | |
Website | psychiatry.med.ualberta.ca/AboutUs/DepartmentMembers/Academic/Baker.aspx |
Research Keywords | biomarkers in psychiatric and neurological disorders, neurochemistry of depression, schizophrenia and anxiety disorders, drug metabolism and drug interactions, neuroprotective drugs |
Additional Information
Lab Methodologies |
|
Apparatus |
|
Roles and Connections
Primary Role | |
CAN Connections |
Most Cited Publications
Noorbakhsh F, Baker GB, Power C, "Allopregnanolone and neuroinflammation: a focus on multiple sclerosis." Frontiers in cellular neuroscience 8, (2014): 134 |
Vivithanaporn P, Asahchop EL, Acharjee S, Baker GB, Power C, "HIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance." AIDS (London, England) 30,4 (2016 Feb 20): 543-52 |
Casey KF, Benkelfat C, Cherkasova MV, Baker GB, Dagher A, Leyton M, "Reduced dopamine response to amphetamine in subjects at ultra-high risk for addiction." Biological psychiatry 76,1 (2014 Jul 1): 23-30 |